237 related articles for article (PubMed ID: 19451138)
1. Molecular forms of natriuretic peptides in heart failure and their implications.
Xu-Cai YO; Wu Q
Heart; 2010 Mar; 96(6):419-24. PubMed ID: 19451138
[TBL] [Abstract][Full Text] [Related]
2. Depressed Corin Levels Indicate Early Systolic Dysfunction Before Increases of Atrial Natriuretic Peptide/B-Type Natriuretic Peptide and Heart Failure Development.
Tripathi R; Wang D; Sullivan R; Fan TH; Gladysheva IP; Reed GL
Hypertension; 2016 Feb; 67(2):362-7. PubMed ID: 26667411
[TBL] [Abstract][Full Text] [Related]
3. Natriuretic Peptides in Heart Failure: Atrial and B-type Natriuretic Peptides.
Maisel AS; Duran JM; Wettersten N
Heart Fail Clin; 2018 Jan; 14(1):13-25. PubMed ID: 29153197
[TBL] [Abstract][Full Text] [Related]
4. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure.
Chen HH; Cataliotti A; Schirger JA; Martin FL; Burnett JC
Am J Physiol Regul Integr Comp Physiol; 2005 May; 288(5):R1093-7. PubMed ID: 15627648
[TBL] [Abstract][Full Text] [Related]
5. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate.
Loke I; Squire IB; Davies JE; Ng LL
Eur J Heart Fail; 2003 Oct; 5(5):599-606. PubMed ID: 14607197
[TBL] [Abstract][Full Text] [Related]
6. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
[TBL] [Abstract][Full Text] [Related]
8. [Functional compartmentation of the endocrine action of cardiac natriuretic peptides].
Haloui M; Arnal JF; Pham I; Gonzalez W; Lyoussi B; Michel JB
Ann Endocrinol (Paris); 2000 Feb; 61(1):32-40. PubMed ID: 10790590
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of atrial and brain natriuretic peptides in the fetoplacental circulation of fetuses with congenital heart diseases.
Miyoshi T; Hosoda H; Miyazato M; Kangawa K; Yoshimatsu J; Minamino N
Placenta; 2019 Aug; 83():26-32. PubMed ID: 31477203
[TBL] [Abstract][Full Text] [Related]
10. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
[TBL] [Abstract][Full Text] [Related]
11. Atrial and brain natriuretic peptides: Hormones secreted from the heart.
Nakagawa Y; Nishikimi T; Kuwahara K
Peptides; 2019 Jan; 111():18-25. PubMed ID: 29859763
[TBL] [Abstract][Full Text] [Related]
12. Plasma atrial and brain natriuretic peptide levels in dogs with congestive heart failure.
Asano K; Masuda K; Okumura M; Kadosawa T; Fujinaga T
J Vet Med Sci; 1999 May; 61(5):523-9. PubMed ID: 10379945
[TBL] [Abstract][Full Text] [Related]
13. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP.
Hogenhuis J; Voors AA; Jaarsma T; Hillege HL; Boomsma F; van Veldhuisen DJ
Eur J Heart Fail; 2005 Jan; 7(1):81-6. PubMed ID: 15642536
[TBL] [Abstract][Full Text] [Related]
14. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure.
Mair J; Hammerer-Lercher A; Puschendorf B
Clin Chem Lab Med; 2001 Jul; 39(7):571-88. PubMed ID: 11522102
[TBL] [Abstract][Full Text] [Related]
15. Are natriuretic peptides clinically useful as markers of heart failure?
Kelly R; Struthers AD
Ann Clin Biochem; 2001 Sep; 38(Pt 5):575-83. PubMed ID: 11587142
[No Abstract] [Full Text] [Related]
16. Are natriuretic peptides clinically useful as markers of heart failure?
Kelly R; Struthers AD
Ann Clin Biochem; 2001 Mar; 38(Pt 2):94-102. PubMed ID: 11269761
[No Abstract] [Full Text] [Related]
17. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure.
Lee SC; Stevens TL; Sandberg SM; Heublein DM; Nelson SM; Jougasaki M; Redfield MM; Burnett JC
J Card Fail; 2002 Jun; 8(3):149-54. PubMed ID: 12140807
[TBL] [Abstract][Full Text] [Related]
18. Measurement and significance of circulating natriuretic peptides in cardiovascular disease.
Sagnella GA
Clin Sci (Lond); 1998 Nov; 95(5):519-29. PubMed ID: 9791037
[TBL] [Abstract][Full Text] [Related]
19. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
[TBL] [Abstract][Full Text] [Related]
20. [Atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP)].
Tsujino M; Hirata Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():577-80. PubMed ID: 16149581
[No Abstract] [Full Text] [Related]
[Next] [New Search]
